In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Too, Inc. phases out Mishmash

This article was originally published in The Rose Sheet

Executive Summary

Too, Inc. is phasing out its 18 Mishmash retail stores targeted to tweens to develop a new concept focused on value-priced sportswear and accessories for girls seven to 14. Mishmash has not reached financial objectives as quickly as planned, the company explains. Mishmash locations not converted to the new store concept will be closed permanently. Newly formatted stores are expected to begin opening in February 2004, company says. The format change is prompted by tween demand for inexpensive clothes, and the perception of high prices within Too's stores, firm notes. Too, Inc. opened its first Mishmash store in 2001. At the time, the company predicted the cosmetics and accessories retailer could become a 650- to 700-store chain (1"The Rose Sheet" Oct. 8, 2001, p. 5)...

You may also be interested in...



Too Inc. Retail Concept Brings Mishmash Of Products To Teen Market

Too Inc.' s new retail concept Mishmash, offering teens a diverse merchandising mix including cosmetics, shoes and intimate apparel, eventually could become a 650-700 store chain, The Limited division said.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011251

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel